Keith M Rich Selected Research

KCC 009

6/2011	Novel chemo-sensitizing agent, ERW1227B, impairs cellular motility and enhances cell death in glioblastomas.
11/2008	Tissue transgluaminase 2 expression in meningiomas.
9/2005	Tissue transglutaminase 2 inhibition promotes cell death and chemosensitivity in glioblastomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Keith M Rich Research Topics

Disease

25	Neoplasms (Cancer) 01/2022 - 01/2003
16	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 01/2003
11	Glioma (Gliomas) 03/2020 - 03/2002
10	Necrosis 01/2022 - 05/2014
7	Brain Neoplasms (Brain Tumor) 01/2021 - 05/2013
6	Meningioma (Meningiomas) 01/2018 - 11/2008
4	Hemorrhage 01/2021 - 02/2013
3	Neoplasm Metastasis (Metastasis) 02/2020 - 01/2013
3	Parkinson Disease (Parkinson's Disease) 01/2020 - 09/2007
3	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 02/2016 - 05/2012
3	Aneurysm (Aneurysms) 01/2016 - 09/2012
3	Stroke (Strokes) 03/2014 - 08/2010
3	Intracranial Aneurysm (Cerebral Aneurysm) 09/2012 - 05/2002
2	Pituitary Neoplasms (Pituitary Adenoma) 02/2020 - 01/2019
2	Hypoxia (Hypoxemia) 01/2018 - 01/2017
2	Melanoma (Melanoma, Malignant) 01/2018 - 01/2013
2	Disease Progression 01/2017 - 03/2009
2	Telangiectasis (Telangiectasia) 07/2014 - 05/2014
2	Carotid Stenosis (Carotid Artery Stenosis) 03/2014 - 01/2013
2	Transient Ischemic Attack 03/2014 - 09/2012
2	Pathologic Constriction (Stenosis) 03/2014 - 09/2012
2	Oligodendroglioma 01/2014 - 07/2004
2	Essential Tremor (Essential Tremors) 08/2006 - 10/2004
2	Tremor (Tremors) 08/2006 - 10/2004
2	Ependymoma 02/2005 - 01/2004
1	Colloid Cysts 02/2022
1	Hypopituitarism (Sheehan's Syndrome) 08/2020
1	Pituitary Diseases (Disease, Anterior Pituitary) 01/2019
1	Inflammation (Inflammations) 01/2018
1	Hyperventilation 01/2017
1	Wounds and Injuries (Trauma) 11/2016
1	Gliosarcoma 10/2016
1	Neurofibrosarcoma (MPNST) 10/2016
1	Intracranial Vasospasm 02/2016
1	Edema (Dropsy) 05/2014
1	Cerebral Hemorrhage 03/2014
1	Nervous System Diseases (Neurological Disorders) 03/2014

Drug/Important Bio-Agent (IBA)

5	Carmustine (FIVB)FDA Link 02/2007 - 07/2004
4	Protein Glutamine gamma Glutamyltransferase 2IBA 06/2011 - 04/2005
4	Proteins (Proteins, Gene)FDA Link 11/2008 - 01/2003
3	Biomarkers (Surrogate Marker)IBA 02/2020 - 01/2015
3	Temozolomide (Temodar)FDA LinkGeneric 02/2020 - 11/2014
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 05/2014
3	Biological ProductsIBA 06/2015 - 05/2013
3	Amino Acids FDA Link 05/2015 - 05/2013
3	KCC 009IBA 06/2011 - 09/2005
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2015
2	Phenylalanine (L-Phenylalanine)FDA Link 12/2020 - 05/2013
2	Hydrocortisone (Cortisol)FDA LinkGeneric 08/2020 - 01/2019
2	AntibodiesIBA 01/2017 - 05/2014
2	Bevacizumab (Avastin)FDA Link 11/2015 - 05/2014
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 08/2013 - 02/2013
2	Apoptosis Regulatory ProteinsIBA 09/2005 - 07/2004
1	HydrogenIBA 01/2022
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2022
1	DeuteriumIBA 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2019
1	SteroidsIBA 01/2019
1	P 11 (P-11)IBA 01/2018
1	plerixafor FDA Link 01/2018
1	Chemokine ReceptorsIBA 01/2018
1	Topotecan (Hycamtin)FDA LinkGeneric 01/2018
1	Nicotinamide PhosphoribosyltransferaseIBA 12/2016
1	NAD (NADH)IBA 12/2016
1	CateninsIBA 10/2016
1	Sildenafil Citrate (Viagra)FDA Link 02/2016
1	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 02/2016
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 06/2015
1	AcidsIBA 05/2015
1	SodiumIBA 05/2015
1	(18F)fluoroethyltyrosineIBA 05/2015
1	Glutamine (L-Glutamine)FDA Link 05/2015
1	Oxygen (Dioxygen)IBA 01/2015
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 07/2014
1	3- (3- chloro- 4- hydroxyphenylamino)- 4- (4- nitrophenyl)- 1H- pyrrole- 2,5- dioneIBA 07/2014
1	Neuroprotective AgentsIBA 07/2014
1	Eosine Yellowish-(YS) (Eosin)IBA 05/2014
1	Hematoxylin (Haematoxylon)IBA 05/2014
1	Tissue Plasminogen Activator (Alteplase)FDA Link 03/2014
1	PlasminogenIBA 03/2014

Therapy/Procedure

12	Therapeutics 01/2021 - 01/2003
10	Radiotherapy 01/2019 - 02/2005
8	Drug Therapy (Chemotherapy) 01/2021 - 04/2004
5	Craniotomy 02/2022 - 01/2002
5	Deep Brain Stimulation 01/2020 - 10/2004
4	Aftercare (After-Treatment) 06/2011 - 05/2002
3	Catheters 02/2013 - 05/2012
2	Immunotherapy 01/2021 - 01/2018
2	Chemoradiotherapy 12/2016 - 01/2014
2	Surgical Instruments (Clip) 01/2016 - 02/2013
2	Carotid Endarterectomy 03/2014 - 01/2013
2	Stents 02/2013 - 09/2012
1	Lasers (Laser) 03/2020
1	Adjuvant Radiotherapy 02/2020
1	Re-Irradiation 01/2018
1	Gastrostomy 01/2017
1	Length of Stay 01/2017
1	Tracheostomy 01/2017
1	Ventriculostomy 01/2017
1	Endovascular Procedures 11/2016